Tg Therapeutics Inc (TGTX)

EBITDA Growth

-42.25%

Quarterly · Period ending:

TGTX logo

TGTX EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-42.25%
TGTX Quarterly EBITDA YoY % (-900.00% → -42.25%)
High-resolution chart · PNG

TGTX ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Tg Therapeutics Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
-42.247%
128.882%
58.6843%
115.5896%
255.6132%
247.8214%
383.1957%
-87.1239%
124.1469%
77.0921%
76.9968%
445.9622%
-17.4937%
45.2326%
45.72%
59.7005%
51.3218%
25.2748%
-6.1103%
1.1573%
-51.7878%
-77.8371%
-130.9069%
-41.6737%
-44.0093%
-45.0304%
30.5325%
-77.7912%
20.4166%
17.3208%
-74.5156%
-7.4895%
-55.3338%
-50.3183%
-32.3038%
-26.7309%
-77.4529%
-97.6723%
-32.9313%
-85.8006%
5.0243%
4.2098%
5.7948%
23.1304%
-40.9768%
-99.4539%
-261.5456%
-304.1037%
-80.3503%
-112.6715%
-100.237%
-73.8923%
79.9607%
15.5794%
-8,205.5524%
100%
-226.9668%
-587.0531%
97.7794%
43.2669%
-893.7125%
-31.0876%
-241.1548%
-10.0323%
4.8782%
-717.2066%
71.3353%
67.4027%
65.3995%
102.8836%
48.9751%
70.2735%
37.7023%
39.6189%
-38.2617%
-109.5867%
-3.8573%
78.1966%
-4.7659%
-57.4686%
-74.2897%
-729.3226%
15.4956%
-56.3405%
-28.3242%
-15.2656%
-10.7191%
-39.7655%
-191.9392%
-328.8874%
-245.9088%
-173.6502%
38.5158%
35.2778%
17.0462%
82.9165%
-213.192%
-123.3578%
26.5956%
52.728%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.